By Joanne Faulkner ( June 19, 2026, 4:00 PM BST) -- The Court of Appeal ruled on Friday that the Competition Appeal Tribunal was wrong to remake a decision to fine Pfizer Ltd. and Flynn Pharma Ltd. £70 million ($93 million) for excessive pricing, finding that the process was tainted by procedural unfairness....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.